Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Angel investors put €390k into Rhenovia Pharma

Executive Summary

Rhenovia Pharma SAS (primarily CNS drug discovery) has raised €390k ($544k) in angel funding. Lead backer Alsace Business Angels' ABA Invest SAS contributed a total of €210k and was joined by Sodiv (€80k), which converted a previous loan into the equity stake, and two other executives. The company says it now has enough money to operate for the next two years.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Bioinformatics
  • Pharmaceuticals
    • Drug Delivery
      • Transdermal
  • Services
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies